|
| Volume 1, Issue 10 |
Artes Medical Develops Breakthrough Product in the $2.5 Billion Aesthetic Market Space
Artes Medical has generated a lot of smiles from physicians and patients since its launch of ArteFill®, the only FDA-approved, long-lasting solution to erasing smile lines. ArteFill is the first truly novel product to be launched into the growing market of facial injectable aesthetic products – 25% per year1. Unlike other fillers, ArteFill has been shown to provide enduring wrinkle correction. The key is its novel formulation, which creates a permanent support structure for continued wrinkle correction that improves over time.
In fact, ArteFill is the first-and-only dermal filler that erases smile lines without the need for repetitive treatments, which may become tiresome as well as expensive, eliminating the “injection fatigue” and “credit card fatigue” experienced by patients receiving temporary dermal fillers. Both physicians and patients have been impressed with the aesthetic improvement provided by ArteFill. Thanks to the efforts of its experienced U.S. sales and marketing team, Artes Medical is capturing market share in the Baby Boomer-fueled dermal filler market.
ArteFill consists of a proprietary combination of ArteFill Precision-Filtered Microspheres™ suspended in a carrier gel containing highly purified bovine collagen with 0.3 percent lidocaine. The microspheres are made of polymethylmethacrylate (PMMA), one of the most commonly used artificial implant materials in medicine. Following injection, the microspheres remain intact at the injection site and provide a permanent structure to support the wrinkle and help prevent further wrinkling. As a result, ArteFill provides patients with aesthetic benefits that may last for years.
For product information, visit www.artefill.com For investor information, call (858) 875-5682 NASDAQ: ARTE artesmedical.com 858.550.9999 | phone
1 2007 American Society for Aesthetic Plastic Surgery (ASAPS)
|
